Cargando…
Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial
BACKGROUND: Fibroadenoma (FA) is the most common benign solid breast mass in women, with no definite method of management. Because fibroadenoma is dependent on female sex hormones and comprises hypertrophic changes at cellular levels, we investigated the effects of metformin (MF), a safe hypoglycemi...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377455/ https://www.ncbi.nlm.nih.gov/pubmed/34416879 http://dx.doi.org/10.1186/s12902-021-00824-4 |